Cargando…

Fear of Recurrence in Chinese Cancer Patients: Prevalence, Correlates, and Network Analysis

BACKGROUND: Fear of cancer recurrence (FCR) is a significant issue for most cancer patients. Until now, a detailed investigation of the structure of FCR and the interaction among its constituent elements is lacking. This study aims to investigate the phenomenon of FCR by means of network analysis in...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Xian, Li, Wengao, Chen, Yu, Sun, Hengwen, Humphris, Gerry, Liu, Ting, Zhang, Jingying, Yang, Yuan, Zhang, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8859333/
https://www.ncbi.nlm.nih.gov/pubmed/35197876
http://dx.doi.org/10.3389/fpsyt.2022.803543
_version_ 1784654434891988992
author Luo, Xian
Li, Wengao
Chen, Yu
Sun, Hengwen
Humphris, Gerry
Liu, Ting
Zhang, Jingying
Yang, Yuan
Zhang, Bin
author_facet Luo, Xian
Li, Wengao
Chen, Yu
Sun, Hengwen
Humphris, Gerry
Liu, Ting
Zhang, Jingying
Yang, Yuan
Zhang, Bin
author_sort Luo, Xian
collection PubMed
description BACKGROUND: Fear of cancer recurrence (FCR) is a significant issue for most cancer patients. Until now, a detailed investigation of the structure of FCR and the interaction among its constituent elements is lacking. This study aims to investigate the phenomenon of FCR by means of network analysis in Chinese cancer patients. METHODS: This is a multi-center, cross-sectional study that included 996 cancer patients from southern China. All participants were assessed by the 7-item Chinese version Fear of Cancer Recurrence Scale (FCR-7). Multivariate logistic regression, and network analyses were conducted. Central symptoms (nodes) in the FCR network were identified. RESULTS: Among the 996 patients, 543 (54.52%) reported moderate FCR, and 137 (13.76%) reported high FCR. Chemotherapy (OR = 2.954, P = 0.016), and childhood severe illness experience (OR = 2.331, P = 0.016) were positively associated with high FCR, while higher monthly income (OR = 0.403, P = 0.046) was negative associated with high FCR. The node #FCR2 (Worried/anxious about recurrence) was the most central node within the FCR network (Strength = 1.190), while node #FCR6 (Examining for physical signs) was the least central node (Strength = 0.373). The edge FCR1-FCR2 (“Afraid”-“Worried/anxious”) was the thickest and most saturated edge in the network. After controlling for age and gender, an almost identical network was obtained with respect to edges magnitude and strength. CONCLUSION: Fear of recurrence is a frequently reported issue among Chinese cancer patients. Patients with chemotherapy and childhood severe illness experience were more vulnerable and should be particularly monitored. Compared to behavioral component (i.e., body checking, overscreening and overtreatment) and cognitive component (i.e., intrusions), emotional component (i.e., worry/anxious) is more central to identify FCR and might be potential targets for further interventions.
format Online
Article
Text
id pubmed-8859333
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-88593332022-02-22 Fear of Recurrence in Chinese Cancer Patients: Prevalence, Correlates, and Network Analysis Luo, Xian Li, Wengao Chen, Yu Sun, Hengwen Humphris, Gerry Liu, Ting Zhang, Jingying Yang, Yuan Zhang, Bin Front Psychiatry Psychiatry BACKGROUND: Fear of cancer recurrence (FCR) is a significant issue for most cancer patients. Until now, a detailed investigation of the structure of FCR and the interaction among its constituent elements is lacking. This study aims to investigate the phenomenon of FCR by means of network analysis in Chinese cancer patients. METHODS: This is a multi-center, cross-sectional study that included 996 cancer patients from southern China. All participants were assessed by the 7-item Chinese version Fear of Cancer Recurrence Scale (FCR-7). Multivariate logistic regression, and network analyses were conducted. Central symptoms (nodes) in the FCR network were identified. RESULTS: Among the 996 patients, 543 (54.52%) reported moderate FCR, and 137 (13.76%) reported high FCR. Chemotherapy (OR = 2.954, P = 0.016), and childhood severe illness experience (OR = 2.331, P = 0.016) were positively associated with high FCR, while higher monthly income (OR = 0.403, P = 0.046) was negative associated with high FCR. The node #FCR2 (Worried/anxious about recurrence) was the most central node within the FCR network (Strength = 1.190), while node #FCR6 (Examining for physical signs) was the least central node (Strength = 0.373). The edge FCR1-FCR2 (“Afraid”-“Worried/anxious”) was the thickest and most saturated edge in the network. After controlling for age and gender, an almost identical network was obtained with respect to edges magnitude and strength. CONCLUSION: Fear of recurrence is a frequently reported issue among Chinese cancer patients. Patients with chemotherapy and childhood severe illness experience were more vulnerable and should be particularly monitored. Compared to behavioral component (i.e., body checking, overscreening and overtreatment) and cognitive component (i.e., intrusions), emotional component (i.e., worry/anxious) is more central to identify FCR and might be potential targets for further interventions. Frontiers Media S.A. 2022-02-07 /pmc/articles/PMC8859333/ /pubmed/35197876 http://dx.doi.org/10.3389/fpsyt.2022.803543 Text en Copyright © 2022 Luo, Li, Chen, Sun, Humphris, Liu, Zhang, Yang and Zhang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Psychiatry
Luo, Xian
Li, Wengao
Chen, Yu
Sun, Hengwen
Humphris, Gerry
Liu, Ting
Zhang, Jingying
Yang, Yuan
Zhang, Bin
Fear of Recurrence in Chinese Cancer Patients: Prevalence, Correlates, and Network Analysis
title Fear of Recurrence in Chinese Cancer Patients: Prevalence, Correlates, and Network Analysis
title_full Fear of Recurrence in Chinese Cancer Patients: Prevalence, Correlates, and Network Analysis
title_fullStr Fear of Recurrence in Chinese Cancer Patients: Prevalence, Correlates, and Network Analysis
title_full_unstemmed Fear of Recurrence in Chinese Cancer Patients: Prevalence, Correlates, and Network Analysis
title_short Fear of Recurrence in Chinese Cancer Patients: Prevalence, Correlates, and Network Analysis
title_sort fear of recurrence in chinese cancer patients: prevalence, correlates, and network analysis
topic Psychiatry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8859333/
https://www.ncbi.nlm.nih.gov/pubmed/35197876
http://dx.doi.org/10.3389/fpsyt.2022.803543
work_keys_str_mv AT luoxian fearofrecurrenceinchinesecancerpatientsprevalencecorrelatesandnetworkanalysis
AT liwengao fearofrecurrenceinchinesecancerpatientsprevalencecorrelatesandnetworkanalysis
AT chenyu fearofrecurrenceinchinesecancerpatientsprevalencecorrelatesandnetworkanalysis
AT sunhengwen fearofrecurrenceinchinesecancerpatientsprevalencecorrelatesandnetworkanalysis
AT humphrisgerry fearofrecurrenceinchinesecancerpatientsprevalencecorrelatesandnetworkanalysis
AT liuting fearofrecurrenceinchinesecancerpatientsprevalencecorrelatesandnetworkanalysis
AT zhangjingying fearofrecurrenceinchinesecancerpatientsprevalencecorrelatesandnetworkanalysis
AT yangyuan fearofrecurrenceinchinesecancerpatientsprevalencecorrelatesandnetworkanalysis
AT zhangbin fearofrecurrenceinchinesecancerpatientsprevalencecorrelatesandnetworkanalysis